MELI vs. CLOV
MELI (MercadoLibre, Inc.) and CLOV (Clover Health Investments, Corp.) are both stocks. MELI operates in Internet Retail (Consumer Cyclical), while CLOV operates in Healthcare Plans (Healthcare). Over the past 5 years, MELI returned 2.68%/yr vs -20.64%/yr for CLOV. At a 0.31 correlation, their price movements are largely independent.
Performance
MELI vs. CLOV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MELI achieves a -21.08% return, which is significantly lower than CLOV's 101.28% return.
MELI
- 1D
- -1.27%
- 1M
- 1.77%
- YTD
- -21.08%
- 6M
- -21.15%
- 1Y
- -32.89%
- 3Y*
- 9.54%
- 5Y*
- 2.68%
- 10Y*
- 28.09%
CLOV
- 1D
- -3.47%
- 1M
- 33.24%
- YTD
- 101.28%
- 6M
- 75.19%
- 1Y
- 61.43%
- 3Y*
- 66.22%
- 5Y*
- -20.64%
- 10Y*
- —
MELI vs. CLOV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
MELI MercadoLibre, Inc. | -21.08% | 18.46% | 8.20% | 85.71% | -37.24% | -19.51% | 95.93% |
CLOV Clover Health Investments, Corp. | 101.28% | -25.40% | 230.85% | 2.43% | -75.01% | -77.82% | 66.53% |
Correlation
The correlation between MELI and CLOV is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.19 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.17 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.33 |
Correlation (All Time) Calculated using the full available price history since Jun 12, 2020 | 0.31 |
The correlation between MELI and CLOV shifts across timeframes, from 0.17 (3 years) to 0.33 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
MELI:
$80.59B
CLOV:
$2.47B
MELI:
$37.87
CLOV:
-$0.11
MELI:
2.63
CLOV:
1.10
MELI:
11.07
CLOV:
7.28
MELI:
$30.67B
CLOV:
$2.21B
MELI:
$13.95B
CLOV:
$939.14M
MELI:
$3.11B
CLOV:
-$55.21M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MELI vs. CLOV — Risk / Return Rank
MELI
CLOV
MELI vs. CLOV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for MercadoLibre, Inc. (MELI) and Clover Health Investments, Corp. (CLOV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MELI | CLOV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.70 | ||
| Sortino ratioReturn per unit of downside risk | -2.65 | ||
| Omega ratioGain probability vs. loss probability | 0.86 | 1.20 | -0.34 |
| Calmar ratioReturn relative to maximum drawdown | -0.81 | 1.11 | -1.92 |
| Martin ratioReturn relative to average drawdown | -1.42 | 2.02 | -3.44 |
Loading charts...
Drawdowns
MELI vs. CLOV - Drawdown Comparison
The maximum MELI drawdown since its inception was -89.49%, smaller than the maximum CLOV drawdown of -97.19%. Use the drawdown chart below to compare losses from any high point for MELI and CLOV.
Loading charts...
Drawdown Indicators
| MELI | CLOV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -89.49% | -97.19% | +7.70% |
Max Drawdown (1Y)Largest decline over 1 year | -40.82% | -55.50% | +14.68% |
Max Drawdown (3Y)Largest decline over 3 years | -40.82% | -64.73% | +23.91% |
Max Drawdown (5Y)Largest decline over 5 years | -68.64% | -95.76% | +27.12% |
Max Drawdown (10Y)Largest decline over 10 years | -69.12% | — | — |
Current DrawdownCurrent decline from peak | -39.18% | -78.65% | +39.47% |
Average DrawdownAverage peak-to-trough decline | -23.58% | -76.59% | +53.01% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 23.24% | 30.46% | -7.22% |
Volatility
MELI vs. CLOV - Volatility Comparison
The current volatility for MercadoLibre, Inc. (MELI) is 9.96%, while Clover Health Investments, Corp. (CLOV) has a volatility of 26.03%. This indicates that MELI experiences smaller price fluctuations and is considered to be less risky than CLOV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MELI | CLOV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.96% | 26.03% | -16.07% |
Volatility (6M)Calculated over the trailing 6-month period | 29.79% | 43.15% | -13.36% |
Volatility (1Y)Calculated over the trailing 1-year period | 39.48% | 71.33% | -31.85% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 49.65% | 77.38% | -27.73% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 48.88% | 85.80% | -36.92% |
Dividends
MELI vs. CLOV - Dividend Comparison
Neither MELI nor CLOV has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CLOV Clover Health Investments, Corp. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
MELI MercadoLibre, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.19% | 0.38% | 0.36% |
Financials
MELI vs. CLOV - Financials Comparison
This section allows you to compare key financial metrics between MercadoLibre, Inc. and Clover Health Investments, Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
MELI vs. CLOV - Profitability Comparison
MELI - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, MercadoLibre, Inc. reported a gross profit of 3.86B and revenue of 7.72B. Therefore, the gross margin over that period was 50.1%.
CLOV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Clover Health Investments, Corp. reported a gross profit of 692.13M and revenue of 749.19M. Therefore, the gross margin over that period was 92.4%.
MELI - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, MercadoLibre, Inc. reported an operating income of 611.00M and revenue of 7.72B, resulting in an operating margin of 7.9%.
CLOV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Clover Health Investments, Corp. reported an operating income of 27.33M and revenue of 749.19M, resulting in an operating margin of 3.7%.
MELI - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, MercadoLibre, Inc. reported a net income of 417.00M and revenue of 7.72B, resulting in a net margin of 5.4%.
CLOV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Clover Health Investments, Corp. reported a net income of 27.33M and revenue of 749.19M, resulting in a net margin of 3.7%.
Frequently Asked Questions
MELI and CLOV have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CLOV has higher volatility (26.03%) compared to MELI (9.96%). In terms of maximum drawdown, MELI dropped -89.49% vs CLOV's -97.19%.
CLOV currently has the higher Sharpe Ratio (0.87 vs -0.84), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MELI and CLOV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer